Related Experiment Video
Updated: May 29, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Association between large vessel vasculitis and inflammatory bowel disease: a case-control study.
François Maillet1, Yann Nguyen2,3, Olivier Espitia4
1Department of Internal Medicine, National Referral Center for Systemic and Autoimmune Disease, Cochin University Hospital, AP-HP, Paris, France.
Large vessel vasculitis (LVV) associated with inflammatory bowel disease (IBD) presents unique characteristics. GCA-IBD patients showed a more severe vascular presentation compared to isolated GCA.
Area of Science:
- Rheumatology
- Gastroenterology
- Vascular Medicine
Background:
- Large vessel vasculitis (LVV), encompassing Takayasu arteritis (TA) and Giant Cell Arteritis (GCA), can co-occur with inflammatory bowel disease (IBD).
- Understanding the distinct features and outcomes of patients with co-existing LVV and IBD is crucial for effective management.
Purpose of the Study:
- To delineate the specific clinical and imaging characteristics of patients with the association of LVV (TA or GCA) and IBD.
- To compare the outcomes of LVV-IBD patients with those of patients with isolated LVV (iLVV).
Main Methods:
- An observational, multicentre, retrospective case-control study was conducted.
- Cases comprised LVV-IBD patients from European countries, while controls consisted of patients with iLVV (iGCA or iTA).
Main Results:
- The study identified 39 TA-IBD and 12 GCA-IBD cases, compared with 52 iGCA and 93 iTA controls.
- LVV occurred after IBD in a significant proportion of patients (56% in TA-IBD, 75% in GCA-IBD).
- TA-IBD patients were younger at diagnosis and experienced more upper limb claudication than iTA controls. GCA-IBD patients exhibited more arterial thickening/stenosis and a trend towards more gastrointestinal artery involvement compared to iGCA controls.
Conclusions:
- This study highlights specific clinical and imaging features of LVV-IBD patients.
- GCA-IBD patients demonstrated a more severe vascular presentation compared to iGCA patients.
- The presence of IBD did not appear to increase the LVV relapse rate.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

